Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
1 minute read

Synaffix Has Announced The Expansion Of Its License Agreement With Macrogenics Adding Up To Four Antibody-drug Conjugates Programs; Expanded Collaboration Includes Up To $2.2B In Total Potential Payments

By Benzinga Newsdesk
Today, 9:57 AM
The expansion comes just a year after the original February 2022 deal, increasing the total potential consideration by up to $2.2 billion, plus tiered low to high single-digit royalties on potential net

MGNX

Read More
1 minute read

Atea Pharmaceuticals Announced The Presentation Of New Phase 1, In Vitro And In Vivo Data That Demonstrate Key Profile Attributes Of Atea’s Lead Drug Candidate, Bemnifosbuvir, For Covid-19 And Hepatitis C

By Benzinga Newsdesk
Today, 9:57 AM
Low risk for drug-drug interactions with bemnifosbuvir based upon results from in vitro metabolism and transporter studies Bemnifosbuvir retains activity against all SARS-CoV-2 variants of concern evaluated as well as

AVIR

Read More
1 minute read

Philips And The Gibraltar Health Authority Have Signed A Long-term Strategic Partnership Continuing Their Long-standing Relationship And Marking Ambitions To Advance Radiology And Cardiology Patient Care

By Benzinga Newsdesk
Today, 9:57 AM
As part of the agreement, the building of a brand-new interventional cardiac suite (cath lab) will commence later this year. The construction and installation of this specialist equipment will take approximately 9-12As part of the agreement, the building of a brand-new interventional cardiac suite (cath lab) will commence later this year.

PHG